© 2017 • Sabin Vaccine Institute • 2175 K Street, NW, Suite 400 • Washington, DC 20037 • +1 202 842 5025
Friday, February 28, 2014
The work of HOOKVAC -- an international consortium which the Sabin Vaccine Institute is a part of -- was recognized for its effort to complete initial human tests on a vaccine for the parasite hookworm.
"The fight against poverty-related diseases is gaining ground as scientists prepare trials of vaccines for hookworm, leishmaniasis and other parasitic diseases common in the developing world, thanks to the support of public research funding.
The problem has been that developing countries harbour most of the planet’s chronic diseases, but attract only a small share of its research funding."